Emisphere Technologies's (Tarrytown...
Emisphere Technologies's (Tarrytown, NY) proof-of-concept application of mind conducted at Medeval Limited (Manchester, UK) showed that an oral formulation of insulin conclusioned in clinically significant absorption from the gastrointestinal tract, with systemic concentrations reaching as high as 26.6-[micro]U/mL. The data also demonstrated a rapid pendant in blood sugar following oral insulin administration, with mean reductions up to 237% as well as declines in mean
|